Skip to content

Microbiota in Dietary Approach to Obesity

Ketone Bodies and Gut Microbiota Role in the Dietetic Approach of Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04453150
Enrollment
150
Registered
2020-07-01
Start date
2020-01-22
Completion date
2022-06-22
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Ketosis, Microbiota

Brief summary

Main aim: Study the anthropometric, metabolic, cardiovascular and neurocognitive and gut microbiota changes of different approaches for the weight reduction that increase the ketone bodies in a different proportion in relation to the classic hypocaloric diet. Objective 1: Study the effect of hypocaloric diets that increase the ketone bodies on gut microbiota and its relationship with anthropometric changes and of the Brown adipose tissue, Objective 2: with the metabolic and inflammatory changes, Objective 3: on the cardiovascular system, Objective 4: on the neurocognition, Objective 5: if they are associated to epigenetic changes that may explain the changes found in the other objectives. Objective 6: Determine the safety of the diets that increase the ketone bodies compared to the classic hypocaloric diet, Objective 7: if the effects of the different dietary approaches are maintained during the medium time, and Objective 8: Verify in experimental models (microbiota transplants from humans with different diets to germ-free mice, ketosis dietary models, and ketone bodies administration) the causality of the gut microbiota of these findings. Methodology: Model 1: Dietary intervention in humans with 4 types of diet with a different increase of the ketone bodies: classic hypocaloric diet (DH); diet with 8h of feeding and 16h of starving in periods of 24h (D16); diet with intermittent caloric restriction (DA); and normal in protein and low in carbohydrates hypocaloric ketogenic diet (DC).

Interventions

OTHERStandard hypocaloric die

Standard hypocaloric diet

OTHERIntermittent fasting 16/8 (early fasting)

Intermittent fasting 16/8 (early fasting)

OTHERIntermittent fasting 16/8 (late fasting)

Intermittent fasting 16/8 (late fasting)

OTHERAlternate-day fasting

Alternate-day fasting

OTHERKetogenic diet

Ketogenic diet

Sponsors

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Obesity (BMI≥30-45 kg/m2)

Exclusion criteria

* Type 2 diabetes mellitus * Patients with major cardiovascular events in the 6 months prior to the study beginning. * Previous or current history of inflammatory disease. * Active infectious disease. * The refusal of the patient to participate in the study * Consumption of probiotics or prebiotics * Antibiotic therapy in the 3 months prior to the study

Design outcomes

Primary

MeasureTime frameDescription
Changes in gut microbiota compositionBaseline, 12 weeksTo evaluate changes in gut microbiota composition from baseline using different strategies for weight loss which increase ketone bodies in comparison to a standard hypocaloric diet. Change from baseline in 16S rRNA amplicons of fecal community DNA at 3 months and 6 months

Secondary

MeasureTime frameDescription
Changes in body mass index.Baseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on body mass index in comparison to a standard hypocaloric diet
Changes in waist circumference.Baseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on the waist circumference in comparison to a standard hypocaloric diet
Changes in body composition.Baseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on anthropometric parameters in comparison to a standard hypocaloric diet measured by bioelectrical impedance analysis
Changes in brown adipose tissue.Baseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on brown adipose tissue in comparison to a standard hypocaloric diet, measured by Positron emission tomography with 18F-fluorodeoxyglucose (18F-FDG PET).
Changes in weightBaseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on anthropometric parameters in comparison to a standard hypocaloric diet
Changes in physical activity.Baseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on physical activity in comparison to a standard hypocaloric diet measured by accelerometry
Changes in blood pressureBaseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies over the cardiovascular system in comparison to a standard hypocaloric diet based on blood pressure
Changes in the punctuation in neurocognitive testBaseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on neurocognition, in comparison to a standard hypocaloric diet, measured by neurocognitive test
Changes in heart rateBaseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on heart function measured by heart rate in comparison to a standard hypocaloric diet, measured by Holter.
Changes in uncoupling protein 1 (UCP1)Baseline, 12 weeksTo analyze the effect of hypocaloric diets which increase ketone bodies on brown adipose tissue UCP1 in comparison to a standard hypocaloric diet using a sample of subcutaneous white adipose tissue assessed by mRNA qPCR.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026